115 related articles for article (PubMed ID: 9382738)
1. Microencapsulation of antigens using biodegradable polyesters: facts and phantasies.
Kissel T; Koneberg R; Hilbert AK; Hungerer KD
Behring Inst Mitt; 1997 Feb; (98):172-83. PubMed ID: 9382738
[TBL] [Abstract][Full Text] [Related]
2. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism.
Kipper MJ; Wilson JH; Wannemuehler MJ; Narasimhan B
J Biomed Mater Res A; 2006 Mar; 76(4):798-810. PubMed ID: 16345084
[TBL] [Abstract][Full Text] [Related]
3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
5. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.
Xing DK; McLellan K; Corbel MJ; Sesardic D
Biologicals; 1996 Mar; 24(1):57-65. PubMed ID: 8733602
[TBL] [Abstract][Full Text] [Related]
6. [Controlled release antigen from the injection site--new model for a single-shot vaccination?].
Gałazka A; Wysokińska T
Postepy Hig Med Dosw; 1998; 52(2):157-72. PubMed ID: 9640979
[TBL] [Abstract][Full Text] [Related]
7. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
8. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
Katare YK; Panda AK
Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
[TBL] [Abstract][Full Text] [Related]
9. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
Jung T; Koneberg R; Hungerer KD; Kissel T
Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
[TBL] [Abstract][Full Text] [Related]
11. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
[TBL] [Abstract][Full Text] [Related]
12. New strategies for the microencapsulation of tetanus vaccine.
Schwendeman SP; Tobío M; Joworowicz M; Alonso MJ; Langer R
J Microencapsul; 1998; 15(3):299-318. PubMed ID: 9608394
[TBL] [Abstract][Full Text] [Related]
13. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
14. [New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres].
Blanco-Prieto MJ; Fattal E; Puisieux F; Couvreur P
Ann Pharm Fr; 1998; 56(6):256-63. PubMed ID: 9872012
[TBL] [Abstract][Full Text] [Related]
15. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
[TBL] [Abstract][Full Text] [Related]
16. Influence of processing on the stability and release properties of biodegradable microspheres containing thioridazine hydrochloride.
O'Donnell PB; McGinity JW
Eur J Pharm Biopharm; 1998 Jan; 45(1):83-94. PubMed ID: 9689539
[TBL] [Abstract][Full Text] [Related]
17. [Long-term immunogenicity and immunologic priming of animals to pulsed controlled-release system for tetanus toxoid vaccine delivery].
He Y; Chen ZH; Wei SL
Yao Xue Xue Bao; 2001 Sep; 36(9):695-8. PubMed ID: 12580111
[TBL] [Abstract][Full Text] [Related]
18. A long acting biodegradable controlled delivery of chitosan microspheres loaded with tetanus toxoide as model antigen.
Varma S; Sadasivan C
Biomed Pharmacother; 2014 Mar; 68(2):225-30. PubMed ID: 24051124
[TBL] [Abstract][Full Text] [Related]
19. Characterization of polymeric poly(epsilon-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids.
Dhanaraju MD; Gopinath D; Ahmed MR; Jayakumar R; Vamsadhara C
J Biomed Mater Res A; 2006 Jan; 76(1):63-72. PubMed ID: 16108044
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres.
Walker KB; Xing DK; Sesardic D; Corbel MJ
Dev Biol Stand; 1998; 92():259-67. PubMed ID: 9554281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
